General Catalyst is a venture capital firm established in 2000 and based in San Francisco, California. The firm specializes in early-stage and growth equity investments across various sectors, including consumer, enterprise, fintech, cryptocurrency, and health assurance. By fostering an environment conducive to growth, General Catalyst aims to accelerate the development of innovative ideas and companies. The firm provides mentorship and connects clients with experienced professionals to enhance their potential for success. As a Registered Investment Adviser, General Catalyst has managed a total of eight venture capital funds, accumulating approximately $3.75 billion in capital commitments.
Two South Park Street Suite 100 San Francisco, CA 94107
434 Broadway Sixth Floor New York, NY 10013
564 University Avenue Palo Alto, CA 94301
20 University Road Fourth Floor Cambridge, MA 02138
Adrian Abeijon
Investor
Mark Allen
CFO
Neeraj Arora
Managing Director, Investment Team
Juliet Bailin
Principal
Marc Bhargava
Managing Director
Larry Bohn
Managing Director
Niko Bonatsos
Managing Director
Teresa Carlson
President, General Catalyst Institute
Kenneth Chenault
Chairman and Managing Director
Mark Crane
Partner
Joel Cutler
Co-Founder and Managing Director
Christopher Davis
Partner
Kyle Doherty
Managing Director
Nick van Eck
Partner
David Fialkow
Co-Founder and Managing Director
Bill Fitzgerald
Managing Director and COO
Diana Hong
Investor
Mina Hsiang
Associate
Nmachi Jidenma
Partner
Christopher Kauffman
Principal
Zak Kukoff
Principal
Paul Kwan
Managing Director
Karanveer Mohan
Managing Director, Investment Team
Priya Mohan
Partner, Investment Team
Deep Nishar
Managing Director
Dipchand Nishar
Managing Director
Reva Nohria
Investor
Trevor Oelschig
Managing Director
Tyler Olkowski
Investor
David Orfao
Managing Director and Co-Founder
Pranay Orugunta
Healthcare Investor
Mo Punjwani
Associate, Investments
Candace Richardson
Principal
Max Rimpel
Partner
Sam Rosen
Growth Investor
Pranav Singhvi
Partner
Bill Skarinka
Associate
Hemant Taneja
CEO and Managing Director
Alex Tran
Managing Director
Catherine Tu
Partner, Investment Team
Adam Valkin
Managing Director
Elena Viboch
Partner
Andrea Wang
Principal, Early Stage Investment
Nathaniel Levy-Westhead
Partner, Investment Team
Deep Nishar
Managing Director and Member of the Management Committee
Roy Mabrey
Partner, Investment Team
Past deals in Health Diagnostics
Neko Health
Series B in 2025
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.
Fay
Series A in 2024
Fay is a company that connects individuals with dietitians covered by their health insurance, promoting improved dietary habits and overall well-being. It offers consulting services focused on medical nutrition therapy, enabling clients to select a dietitian and arrange either virtual or in-person consultations. Fay designs personalized nutrition plans tailored to each client's needs and works with insurance providers to ensure that these services are accessible and affordable. By facilitating customized nutrition counseling, Fay aims to enhance food-related health outcomes for its clients.
Hona AI
Seed Round in 2024
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.
Hippocratic AI
Series A in 2024
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Eleanor Health
Venture Round in 2024
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Established in 2019 and headquartered in Waltham, Massachusetts, Eleanor Health offers comprehensive, whole-person care for mental health and substance misuse. Its services include evidence-based outpatient care, medication-assisted treatment for addiction, and personalized recovery plans, which are delivered through a network of outpatient clinics, virtually, and in community and home settings. This integrated approach aims to expedite the recovery process for individuals suffering from substance use disorders.
Commure
Venture Round in 2023
Commure, Inc. is a technology company that develops an open platform aimed at healthcare software developers, enabling the creation and deployment of advanced healthcare applications. The platform is built on the open HL7 FHIR standard and offers various features, including an FHIR API server, security framework, event service bus, EHR integration, and a flexible data store. Commure's solutions facilitate the unification of disparate datasets, providing meaningful insights and enhancing performance through intuitive applications. The company collaborates with health systems, digital innovators, and payors to foster a vibrant healthcare ecosystem, ultimately empowering clinicians and staff to improve patient care. Established in 2017, Commure is headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota.
Neko Health
Series A in 2023
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.
Zageno
Venture Round in 2023
Zageno Inc. is an online retailer specializing in life science research products, aiming to streamline the purchasing process for researchers globally. Founded in 2015 and headquartered in Cambridge, Massachusetts, Zageno offers a diverse range of over 10 million products, including preparation items, gene editing tools, PCR products, sequencing kits, and various detection and lab accessories. The company features a unique Scientific Score, which provides unbiased, peer-reviewed ratings to assist customers in making informed purchasing decisions. Zageno's platform is designed to enhance convenience and efficiency in acquiring research materials, serving as a reliable sales channel for suppliers and partners in the biotechnology sector. The company also has an office in Berlin, Germany, reflecting its commitment to fostering scientific innovation.
Hippocratic AI
Seed Round in 2023
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Memora Health
Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Paradigm
Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.
Breathe Well-being
Series B in 2023
Breathe Well-being is a health technology startup based in India that focuses on managing and preventing type 2 diabetes through a clinically proven program. The company assists individuals with chronic conditions, such as diabetes, in their weight loss efforts by providing personalized one-on-one coaching. Users receive guidance on tracking their weight, meals, and activities, while also learning cognitive behavioral therapy techniques to manage stress. Breathe Well-being promotes long-term healthy habits through individual lifestyle tracking and personalized counseling, complemented by social interactions and community challenges. The program has successfully helped over 10,000 members lose weight, lower blood sugar levels, and reduce the risk of health complications.
Fay
Seed Round in 2023
Fay is a company that connects individuals with dietitians covered by their health insurance, promoting improved dietary habits and overall well-being. It offers consulting services focused on medical nutrition therapy, enabling clients to select a dietitian and arrange either virtual or in-person consultations. Fay designs personalized nutrition plans tailored to each client's needs and works with insurance providers to ensure that these services are accessible and affordable. By facilitating customized nutrition counseling, Fay aims to enhance food-related health outcomes for its clients.
Disclo
Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.
Fitmint
Seed Round in 2022
Fitmint is a ultimate fitness app that tracks your workouts and rewards you in $FITT tokens for each calorie you burn.
Examedi
Series A in 2022
Examedi is a healthcare startup that provides nurse and lab technician services directly at patients' homes for appointments. Examedi connects the availabilities of healthcare providers with patients.
Orange Health Labs
Series B in 2022
Orange Health Labs is a health tech startup focused on providing diagnostic lab services that enable doctors to deliver care remotely. The company aims to enhance patient convenience by allowing individuals to receive home sample collection and access to test results without the need for clinic visits. By adopting a patient-centric approach, Orange Health helps reduce wait times for test results and facilitates efficient testing for blood tests, checkups, and pathology services. This innovative model supports the vision of making healthcare more accessible and seamless for consumers in their homes.
Loop
Series B in 2022
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.
Eleanor Health
Series C in 2022
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Established in 2019 and headquartered in Waltham, Massachusetts, Eleanor Health offers comprehensive, whole-person care for mental health and substance misuse. Its services include evidence-based outpatient care, medication-assisted treatment for addiction, and personalized recovery plans, which are delivered through a network of outpatient clinics, virtually, and in community and home settings. This integrated approach aims to expedite the recovery process for individuals suffering from substance use disorders.
Alinea Health
Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.
Ro
Venture Round in 2022
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.
Casana
Series B in 2022
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.
The Breakaway
Seed Round in 2022
The Breakaway develops a motivational coaching app designed for cyclists. The platform features smart goals and personalized insights to help users progress faster. It also includes motivational feedback and tips from top pros to ensure users are focused and learning as they go.
Well
Series B in 2021
Well Dot, Inc. is a health technology company that has developed an artificial intelligence-based consumer health engagement platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Massachusetts, New York, and Minnesota, Well's platform uses clinical and consumer data to offer personalized health guidance and support. It analyzes individual health triggers to promote tailored, achievable steps for members to improve their health. The platform is designed to engage, educate, and empower users, providing easy-to-understand explanations and active assistance from health teams. By focusing on creating a meaningful and personalized health journey, Well aims to motivate individuals to adopt healthier habits and achieve better health outcomes.
Cadence Solutions
Series B in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.
Ophelia
Series B in 2021
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in New York, New York.
Sword Health
Series D in 2021
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.
Shyft
Seed Round in 2021
Shyft is a personalized wellness platform that offers guided nutrition, meditation, and yoga classes. Shyft offers a variety of Yoga based interactive classes and DIY content focused on managing specific conditions across women's health, chronic ailments, everyday wellness, and mental health.
Zageno
Series C in 2021
Zageno Inc. is an online retailer specializing in life science research products, aiming to streamline the purchasing process for researchers globally. Founded in 2015 and headquartered in Cambridge, Massachusetts, Zageno offers a diverse range of over 10 million products, including preparation items, gene editing tools, PCR products, sequencing kits, and various detection and lab accessories. The company features a unique Scientific Score, which provides unbiased, peer-reviewed ratings to assist customers in making informed purchasing decisions. Zageno's platform is designed to enhance convenience and efficiency in acquiring research materials, serving as a reliable sales channel for suppliers and partners in the biotechnology sector. The company also has an office in Berlin, Germany, reflecting its commitment to fostering scientific innovation.
Better Health
Series A in 2021
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.
Sprinter Health
Series A in 2021
Sprinter Health is an on-demand mobile health company that sends full-time nurses and phlebotomists (“Sprinters”) into the home.
Loop
Series A in 2021
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.
Orange Health Labs
Series A in 2021
Orange Health Labs is a health tech startup focused on providing diagnostic lab services that enable doctors to deliver care remotely. The company aims to enhance patient convenience by allowing individuals to receive home sample collection and access to test results without the need for clinic visits. By adopting a patient-centric approach, Orange Health helps reduce wait times for test results and facilitates efficient testing for blood tests, checkups, and pathology services. This innovative model supports the vision of making healthcare more accessible and seamless for consumers in their homes.
Breathe Well-being
Series A in 2021
Breathe Well-being is a health technology startup based in India that focuses on managing and preventing type 2 diabetes through a clinically proven program. The company assists individuals with chronic conditions, such as diabetes, in their weight loss efforts by providing personalized one-on-one coaching. Users receive guidance on tracking their weight, meals, and activities, while also learning cognitive behavioral therapy techniques to manage stress. Breathe Well-being promotes long-term healthy habits through individual lifestyle tracking and personalized counseling, complemented by social interactions and community challenges. The program has successfully helped over 10,000 members lose weight, lower blood sugar levels, and reduce the risk of health complications.
Athelas
Series B in 2021
Athelas, Inc. is a healthcare company based in Mountain View, California, that specializes in developing and manufacturing in-home blood analysis devices aimed at diagnosing infections, inflammations, and malignancies. Founded in 2002, Athelas has created a portable optical unit that analyzes blood samples from a single drop, providing diagnostic reports to monitor the immune system. The company's FDA-cleared device is designed to help chronically ill patients manage their health at home, offering additional monitoring for blood pressure, weight, glucose levels, and medication adherence. This technology enables patients to monitor their immunity and assists healthcare providers in the early detection of conditions such as leukemia and other inflammatory diseases. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.
Cadence Solutions
Series A in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.
OM1
Series D in 2021
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.
Sword Health
Series C in 2021
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.
Terra API
Seed Round in 2021
Terra API specializes in facilitating the seamless transfer of health data between various applications and devices. The company provides an online application programming interface (API) that enables developers to connect easily with health apps, wearables, sensors, and blood laboratories. By utilizing standard protocols for data exchange, Terra API allows applications to accept requests and return responses in commonly used formats, supporting efficient communication across diverse fitness tracking devices. This integration empowers users to share and access their health and fitness data from multiple sources, enhancing the overall user experience in health management.
Ophelia
Series A in 2021
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in New York, New York.
Hallow
Series A in 2021
Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleeping soundly every night. It was founded in 2018 and is based in Chicago, Illinois.
Tempo
Series C in 2021
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.
Ro
Series D in 2021
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.
Ossium Health
Series B in 2021
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.
Truvian Sciences
Series C in 2021
Truvian Sciences Inc, based in San Diego, California, specializes in developing automated diagnostic equipment that transforms the blood testing industry. Founded in 2015, the company offers a benchtop system designed to deliver lab-accurate results for a range of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all processed from a single sample. Additionally, Truvian Sciences provides a software platform that enables healthcare practitioners to efficiently share test data with patients.
Casana
Series A in 2021
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.
Elephant Healthcare
Series A in 2021
Elephant Healthcare Limited, founded in 2018 and based in London, develops a digital health system aimed at revolutionizing global healthcare. The company constructs a global digital health network that links various components of the healthcare ecosystem. Founded by medical professionals, Elephant leverages technological innovations to tackle significant challenges in healthcare, focusing on cost reduction and improving patient outcomes. Its software platform digitizes medical clinics, fostering connectivity and providing tools to enhance primary care. Additionally, the platform utilizes blockchain and decentralized infrastructure to integrate existing services and facilitate the development of new health applications, particularly benefiting hospitals serving low-income populations.
Curai Health
Series B in 2020
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company leverages artificial intelligence to provide chat-based primary care services, aiming to make high-quality and affordable healthcare accessible to everyone, anytime. Curai Health's platform integrates clinicians with advanced AI and machine learning tools to create a learning healthcare system that enhances the efficiency and cost-effectiveness of medical care. By facilitating better communication between patients and healthcare professionals, the platform aids in accurate diagnosis and treatment. Curai Health offers its services directly to consumers and through partnerships with enterprises.
Story Health
Seed Round in 2020
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtualized clinical care software tools aimed at aiding healthcare specialists, particularly neurologists and primary care physicians. The company offers a comprehensive healthcare technology platform that includes virtual patient programs, therapy management, and analytics designed to bridge the gap between clinical evidence and patient experiences. By utilizing data from high-frequency sources, Story Health empowers clinicians to better understand medical situations and make informed decisions regarding the physiological impacts of diseases and therapies. Through its innovative approach, Story Health enhances the ability of specialists to deliver effective patient care.
Tempo
Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.
Ro
Series C in 2020
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.
Ophelia
Seed Round in 2020
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in New York, New York.
Karius
Series B in 2020
Karius, Inc. is a life sciences company based in Redwood City, California, specializing in genomic insights for infectious diseases. The company offers a non-invasive blood test known as the Karius Test, which utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. By mapping the microbial landscape of each patient from a single blood draw, Karius aims to assist clinicians in making rapid and informed treatment decisions. The company's laboratory is CLIA-certified and CAP-accredited, ensuring high standards in clinical laboratory testing. Additionally, Karius provides laboratory services for pathogen biomarker detection tailored to biopharmaceutical companies.
Well
Seed Round in 2019
Well Dot, Inc. is a health technology company that has developed an artificial intelligence-based consumer health engagement platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Massachusetts, New York, and Minnesota, Well's platform uses clinical and consumer data to offer personalized health guidance and support. It analyzes individual health triggers to promote tailored, achievable steps for members to improve their health. The platform is designed to engage, educate, and empower users, providing easy-to-understand explanations and active assistance from health teams. By focusing on creating a meaningful and personalized health journey, Well aims to motivate individuals to adopt healthier habits and achieve better health outcomes.
Zageno
Series B in 2019
Zageno Inc. is an online retailer specializing in life science research products, aiming to streamline the purchasing process for researchers globally. Founded in 2015 and headquartered in Cambridge, Massachusetts, Zageno offers a diverse range of over 10 million products, including preparation items, gene editing tools, PCR products, sequencing kits, and various detection and lab accessories. The company features a unique Scientific Score, which provides unbiased, peer-reviewed ratings to assist customers in making informed purchasing decisions. Zageno's platform is designed to enhance convenience and efficiency in acquiring research materials, serving as a reliable sales channel for suppliers and partners in the biotechnology sector. The company also has an office in Berlin, Germany, reflecting its commitment to fostering scientific innovation.
Curai Health
Series A in 2018
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company leverages artificial intelligence to provide chat-based primary care services, aiming to make high-quality and affordable healthcare accessible to everyone, anytime. Curai Health's platform integrates clinicians with advanced AI and machine learning tools to create a learning healthcare system that enhances the efficiency and cost-effectiveness of medical care. By facilitating better communication between patients and healthcare professionals, the platform aids in accurate diagnosis and treatment. Curai Health offers its services directly to consumers and through partnerships with enterprises.
OM1
Series B in 2018
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.
Ro
Seed Round in 2017
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.
Commure
Seed Round in 2017
Commure, Inc. is a technology company that develops an open platform aimed at healthcare software developers, enabling the creation and deployment of advanced healthcare applications. The platform is built on the open HL7 FHIR standard and offers various features, including an FHIR API server, security framework, event service bus, EHR integration, and a flexible data store. Commure's solutions facilitate the unification of disparate datasets, providing meaningful insights and enhancing performance through intuitive applications. The company collaborates with health systems, digital innovators, and payors to foster a vibrant healthcare ecosystem, ultimately empowering clinicians and staff to improve patient care. Established in 2017, Commure is headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota.
OM1
Series A in 2017
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.
SynapDx
Series B in 2012
SynapDx is a laboratory testing service provider focused on the early detection of autism spectrum disorders (ASDs) in children. Founded by Stanley Lapidus, the company aims to assist physicians in evaluating developmental disorders through innovative blood-based diagnostic tests and equipment. By collaborating with experts in ASD and gene expression from prominent institutions, SynapDx seeks to enhance the capability of healthcare providers to identify early symptoms of autism. The company is headquartered in Lexington, Massachusetts, and has secured funding from notable investors, including North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners.
OvaScience
Series B in 2012
OvaScience, Inc. was a fertility company focused on developing innovative treatments for women facing infertility challenges. The company was founded in 2011 and was headquartered in Waltham, Massachusetts. OvaScience specialized in proprietary technology derived from the discovery of egg precursor (EggPC) cells, which allowed for the enhancement of egg quality and improved outcomes in in vitro fertilization (IVF). Their treatment options included OvaPrime, which aimed to restore a woman's egg production using her own EggPC cells, OvaTure, designed to mature these cells into fertilizable eggs outside the body, and AUGMENT, which utilized mitochondria from EggPC cells to enhance fertilization and pregnancy rates. The company also explored OvaXon for preventing inherited diseases. OvaScience was co-founded by a team of experts from Harvard Medical School and was backed by prominent life science investors. In December 2018, OvaScience was acquired by Millendo Therapeutics in a reverse merger.
Lose It!
Series A in 2012
Lose It! is a weight loss application that aims to help individuals achieve and maintain a healthy weight through personalized tracking and community support. The platform allows users to set specific weight loss goals, track their daily food intake and exercise, and access a global community for continuous encouragement. Each member receives a customized plan and daily calorie budget based on their personal information and health objectives. Lose It! employs user-friendly tracking tools and a comprehensive database of food and exercise options, empowering users to manage their weight effectively. The application is grounded in nutritional science and behavioral data, promoting healthier living and fostering a supportive environment for its members.
SynapDx
Series A in 2010
SynapDx is a laboratory testing service provider focused on the early detection of autism spectrum disorders (ASDs) in children. Founded by Stanley Lapidus, the company aims to assist physicians in evaluating developmental disorders through innovative blood-based diagnostic tests and equipment. By collaborating with experts in ASD and gene expression from prominent institutions, SynapDx seeks to enhance the capability of healthcare providers to identify early symptoms of autism. The company is headquartered in Lexington, Massachusetts, and has secured funding from notable investors, including North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners.
Lose It!
Seed Round in 2010
Lose It! is a weight loss application that aims to help individuals achieve and maintain a healthy weight through personalized tracking and community support. The platform allows users to set specific weight loss goals, track their daily food intake and exercise, and access a global community for continuous encouragement. Each member receives a customized plan and daily calorie budget based on their personal information and health objectives. Lose It! employs user-friendly tracking tools and a comprehensive database of food and exercise options, empowering users to manage their weight effectively. The application is grounded in nutritional science and behavioral data, promoting healthier living and fostering a supportive environment for its members.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.